<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39379681</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Long COVID at 3 and 6 months after covid-19 infection in Thailand.</ArticleTitle><Pagination><StartPage>23441</StartPage><MedlinePgn>23441</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">23441</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-75233-3</ELocationID><Abstract><AbstractText>"Long COVID", which describes a diverse set of symptoms or conditions that persist or develop after four weeks from the onset of initial SARS-CoV-2 infection has been introduced. However, the true prevalence varies worldwide. This study aimed to determine the point prevalence and clinical characteristics of long COVID at three and six months after acute COVID-19 infection in Thailand. Methods All adult patients who were diagnosed with COVID-19 by positive nasopharyngeal RT-PCR for SARS-CoV-2 at Thammasat University Hospital between October and December 2021 were recruited and followed for long COVID symptoms by telephone interviews at 3 and 6 months after an acute infection. Among 1,400 eligible COVID-19 cases, interviews were complete for 1,129 and 932 individuals at 3 and 6 months, respectively. Of those, 431 and 314 reported at least one symptom consistent with long COVID. The point prevalence was 38.2% (95% confidence interval: 35.3-41.1%) and 33.7% (95% confidence interval: 30.7-36.7%) respectively. Female gender, disease severity, and symptomatic acute infection were identified as independent risk factors. Conclusion Based on the reported symptoms, long COVID is commonly observed either at 3 or 6 months in our study.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rutjanawech</LastName><ForeName>Sasinuch</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Faculty of Medicine, Thammasat University, Pathumthani, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sritipsukho</LastName><ForeName>Paskorn</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Center of Excellence in Applied Epidemiology, Thammasat University, Pathumthani, Thailand. paskorn100@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine, Thammasat University, Pathumthani, Thailand. paskorn100@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sritipsukho</LastName><ForeName>Sirinda</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>65-050</GrantID><Agency>Health Systems Research Institute, Thailand</Agency><Country/></Grant><Grant><GrantID>65-050</GrantID><Agency>Health Systems Research Institute, Thailand</Agency><Country/></Grant><Grant><GrantID>65-050</GrantID><Agency>Health Systems Research Institute, Thailand</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013785" MajorTopicYN="N" Type="Geographic">Thailand</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">3 months</Keyword><Keyword MajorTopicYN="N">6 months</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Thailand</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>0</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>23</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39379681</ArticleId><ArticleId IdType="pmc">PMC11461650</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-75233-3</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-75233-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. Pneumonia of unknown cause &#x2013; China [Internet]. World Health Organization; 5 Jan 2020 [cited 31 Jan 2024]. https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/</Citation></Reference><Reference><Citation>World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. World Health Organization; [cited 31 Jan 2024]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it</Citation></Reference><Reference><Citation>Center for Disease Control and Prevention. Long COVID or Post-COVID Conditions. Center for Disease Control and Prevention; [cited 1 Feb 2024]. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html#:~:text=Long%20COVID%20is%20broadly%20defined,after%20acute%20COVID%2D19%20infection</Citation></Reference><Reference><Citation>Davis, H. E., McCorkell, L., Vogel, J. M., Topol, E. J. &amp; Long, C. O. V. I. D. Major findings, mechanisms, and recommendations. Nat. Rev. Microbiol.&#xa0; 21 (3), 133&#x2013;146. 10.1038/s41579-022-00846-2 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>No author &amp; Long, C. O. V. I. D. 3 years in. Lancet. 401 (10379), 795. 10.1016/S0140-6736(23)00493-2 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9998094</ArticleId><ArticleId IdType="pubmed">36906338</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Clinical management of COVID-19: interim guidance, 27 May 2020. Geneva: World Health Organization 2020, 2020. WHO/2019-nCoV/clinical/2020.5. https://iris.who.int/bitstream/handle/10665/332196/WHO-2019-nCoV-clinical-2020.5-eng.pdf</Citation></Reference><Reference><Citation>Lopez-Leon, S. et al. More than 50 long-term effects of COVID-19: a systematic review and metaanalysis. Sci. Rep.&#xa0; 11 (1), 16144 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai, A. D., Lavelle, M., Boursiquot, B. C. &amp; Wan, E. Y. Long term complications of COVID-19. Am. J. Phisyol Cell. Physiol. 2022; Jan 1; 322(1): C1&#x2013;C11. 10.1152/aipcell.00375.2021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8721906</ArticleId><ArticleId IdType="pubmed">34817268</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg, B. et al. Et. Al. Long COVID in a prospective cohort of home-isolated patients. Nat. Med.&#xa0; 27, 1607&#x2013;1613 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes, D. L. et al. Post-COVID-19 symptom burden: what is long-COVID and how to manage it. Lung. 199, 113&#x2013;119 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi, G., Sanchis-Gomar, F. &amp; Henry, B. M. COVID-19 and its long-term sequelae: what do we known in 2023? Pol Arch Intern Med. ; Apr 19;133(4):16402. Doi: (2023). 10.20452/pamw.16402. Epub 2023 Jan 9.</Citation><ArticleIdList><ArticleId IdType="pubmed">36626183</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet, M. et al. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med.&#xa0; 18, e1003773 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Jahdhami, I., Al-Naamani, K. &amp; Al-Mawali, A. The post-acute COVID-19 syndrome (long COVID). Oman Med. J.&#xa0; 36 (1), e220. 10.5001/omj.2021.91 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7838343</ArticleId><ArticleId IdType="pubmed">33537155</ArticleId></ArticleIdList></Reference><Reference><Citation>Helena, C., Maltezou, A., Pavli, A. &amp; Tsakris Post-COVID syndrome: an insight on its pathogenesis. Vaccines. 9 (5), 497. 10.3390/vaccines9050497 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8151752</ArticleId><ArticleId IdType="pubmed">34066007</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, C. et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 397, 220&#x2013;232 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanichkachorn, G. et al. Post-COVID-19 syndrome (Long Haul Syndrome): description of a multidisciplinary clinic at Mayo clinic and characteristics of the initial patient cohort. Mayo Clin. Proc.&#xa0; 96, 1782&#x2013;1791 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8112396</ArticleId><ArticleId IdType="pubmed">34218857</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh, T., Knight, M., A&#x2019;Court, C., Buxton, M. &amp; Husain, L. Management of post-acute COVID-19 in primary care. Brit Med. J.&#xa0; 370, m3026 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai, F. et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin. Microbiol. Infect.&#xa0; 28, 611e9&#x2013;611e16 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya, A. A. et al. et.al. Risk factors associated with long COVID syndrome: a retrospective study. Iran. J. Med. Sci. 2021.&#xa0; 46; 428&#x2013;436 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8611223</ArticleId><ArticleId IdType="pubmed">34840383</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayaaslan, B. et al. Post-COVID syndrome: a single center questionnaire study on 1007 participants recovered from COVID-19. J. Med. Virol.&#xa0; 93, 6566&#x2013;6574 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8426910</ArticleId><ArticleId IdType="pubmed">34255355</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunguang, H., Liu, Y. &amp; Zheng, H. Longding Liu. Risk factors for long COVID in older adults. Biomedicines ; 11(11). (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10669899</ArticleId><ArticleId IdType="pubmed">38002002</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe, A., Iwagami, M., Yasuhara, J., Takagi, H. &amp; Kuno, T. Protective effect of COVID-19 vaccination against long COVID syndrome: a systematic review and meta-analysis. Vaccine. 41, 1783&#x2013;1790 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9905096</ArticleId><ArticleId IdType="pubmed">36774332</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>